Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
San Francisco AI company building persistent intelligent NPCs for gaming with 1M+ Roblox users in month one; $6.7M raised competing with Inworld AI for game character intelligence and social deduction AI.
ego AI is a San Francisco-based AI company building persistent, intelligent AI characters for gaming environments — creating non-player characters (NPCs) that exhibit human-like reasoning, memory, and adaptive behavior in 3D gaming worlds and social deduction games. Founded in 2023 and backed with $6.7 million in early seed funding, ego AI achieved over 1 million users in its first month through a Roblox experience, partnered with MEE6 for Discord integration, and launched Accomplice (an AI-powered social deduction game), while collaborating with Singapore's government on AI infrastructure research.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.